| John J Kelemen Iii, MD | |
|
25 Hospital Center Blvd Ste 306, Hilton Head Island, SC 29926-2739 | |
| (843) 689-8224 | |
| (843) 689-8360 |
| Full Name | John J Kelemen Iii |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 33 Years |
| Location | 25 Hospital Center Blvd Ste 306, Hilton Head Island, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871554212 | NPI | - | NPPES |
| 200326510A | Medicaid | KS | |
| 200326510D | Medicaid | KS | |
| 201291370 | Medicaid | IN | |
| 000001006309 | Other | IN | ANTHEM PROVIDER NUMBER |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Heart Hospital Baylor Denton | Denton, TX | Hospital |
| Medical City Denton | Denton, TX | Hospital |
| Baylor Scott & White The Heart Hospital - Plano | Plano, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthtexas Provider Network | 1355254210 | 1810 |
News Archive
Many cells are covered with mysterious large holes, pores that have been associated with the sense of taste as well as Alzheimer's disease, depression, and even asthma. Knowing the structure of these varied holes will help researchers better understand this range of associations and provide a blueprint for developing new therapies.
Oncothyreon Inc. today announced that Merck KGaA, Darmstadt, Germany, has initiated the international Phase 3 START2 study, which is designed to assess the efficacy and safety of the investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) in patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC).
Scientists at the University of North Carolina at Chapel Hill schools of medicine and pharmacy have been awarded a $3 million federal grant to develop and test a new generation of treatments aimed at preventing sexual transmission of HIV to uninfected individuals.
Lawmakers and witnesses on Wednesday at a Senate Special Committee on Aging hearing discussed recommendations for increased regulations on direct-to-consumer advertisements for medical devices, Dow Jones reports (Corbett Dooren, Dow Jones, 9/17).
› Verified 9 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Many cells are covered with mysterious large holes, pores that have been associated with the sense of taste as well as Alzheimer's disease, depression, and even asthma. Knowing the structure of these varied holes will help researchers better understand this range of associations and provide a blueprint for developing new therapies.
Oncothyreon Inc. today announced that Merck KGaA, Darmstadt, Germany, has initiated the international Phase 3 START2 study, which is designed to assess the efficacy and safety of the investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) in patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC).
Scientists at the University of North Carolina at Chapel Hill schools of medicine and pharmacy have been awarded a $3 million federal grant to develop and test a new generation of treatments aimed at preventing sexual transmission of HIV to uninfected individuals.
Lawmakers and witnesses on Wednesday at a Senate Special Committee on Aging hearing discussed recommendations for increased regulations on direct-to-consumer advertisements for medical devices, Dow Jones reports (Corbett Dooren, Dow Jones, 9/17).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John J Kelemen Iii, MD Po Box 21964, Belfast, ME 04915-4116 Ph: (708) 342-6900 | John J Kelemen Iii, MD 25 Hospital Center Blvd Ste 306, Hilton Head Island, SC 29926-2739 Ph: (843) 689-8224 |
News Archive
Many cells are covered with mysterious large holes, pores that have been associated with the sense of taste as well as Alzheimer's disease, depression, and even asthma. Knowing the structure of these varied holes will help researchers better understand this range of associations and provide a blueprint for developing new therapies.
Oncothyreon Inc. today announced that Merck KGaA, Darmstadt, Germany, has initiated the international Phase 3 START2 study, which is designed to assess the efficacy and safety of the investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) in patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC).
Scientists at the University of North Carolina at Chapel Hill schools of medicine and pharmacy have been awarded a $3 million federal grant to develop and test a new generation of treatments aimed at preventing sexual transmission of HIV to uninfected individuals.
Lawmakers and witnesses on Wednesday at a Senate Special Committee on Aging hearing discussed recommendations for increased regulations on direct-to-consumer advertisements for medical devices, Dow Jones reports (Corbett Dooren, Dow Jones, 9/17).
› Verified 9 days ago